Sotera Health Company

The momentum for this stock is not very good. Sotera Health Company has good growth characteristics. Sotera Health Company is not very popular among insiders. Tradey thinks it is not wise to invest in Sotera Health Company.
Log in to see more information.

News

Principal Financial Group Inc. Sells 53,668 Shares of Sotera Health (NASDAQ:SHC)
Principal Financial Group Inc. Sells 53,668 Shares of Sotera Health (NASDAQ:SHC)

Ticker Report Principal Financial Group Inc. lowered its position in shares of Sotera Health (NASDAQ:SHC - Free Report) by 11.5% in the second quarter, according to its most recent disclosure with the SEC. The...\n more…

Sotera Health Stock Earns 91 RS Rating
Sotera Health Stock Earns 91 RS Rating

Investor's Business Daily A Relative Strength Rating upgrade for Sotera Health shows improving technical performance.\nThe post Sotera Health Stock Earns 91 RS Rating appeared first on Investor's Business Daily...\n more…

Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc Sells 10,000,000 Shares
Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc Sells 10,000,000 Shares

Ticker Report Sotera Health (NASDAQ:SHC - Get Free Report) Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of...\n more…

What's Going On With Sotera Health (SHC) Stock?
What's Going On With Sotera Health (SHC) Stock?

Benzinga Sotera Health shares are trading higher by 5.5% during Thursday's session. The company late Wednesday announced a secondary offering of 25 million shares.\n more…

Sotera Health Announces Secondary Offering of Common Stock
Sotera Health Announces Secondary Offering of Common Stock

Globe Newswire CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the Company ) today announced the launch of a secondary offering (the Offering ) of 25,000,000 shares of its...\n more…

Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable
Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Simply Wall St With a median price-to-sales (or "P/S") ratio of close to 3.8x in the Life Sciences industry in the United States, you...\n more…